Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, epidemiology of
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, familial
amyotrophic lateral sclerosis, guamian type of
amyotrophic lateral sclerosis, Parkinson-dementia-complex
arthrogryposis multiplex
central core disease
Charcot-Marie-Tooth
cycad seed flour
degenerative diseases of CNS
dementia
diet
epidemiology of neurology
familial
Fazio-Londe's disease
genetic neurologic disorders
Hallervorden Spatz disease
heavy metal intoxication
herpes virus infection
HLA
immunosuppression
inclusion bodies
inclusion bodies, eosinophilic cytoplasmic
Jakob-Creutzfeldt disease
Kugelberg-Welander syndrome
lead poisoning
mongolism
motor neuron disease
myasthenia gravis
myotonia dystrophica
neurofibrillary degeneration
neuronal ceroid-lipofuscinosis
neurotoxin
Parkinson disease
Parkinson disease, postencephalitic
Parkinsonism-dementia complex
poison, mercury
poison, neurologic problems with
prognosis
smell
Smell Identification Test
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
tricresylphosphate
tuberous sclerosis
viral infection, CNS
Werdnig-Hoffman disease
Showing articles 1000 to 1050 of 4200 << Previous Next >>

Is It All Cerebral Toxoplasmosis?
Lancet 379:286, Mentzer,A.,et al, 2012

Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study
JNNP 83:49-54, Calabrese, M.,et al, 2012

Intraventricular Hemorrhage
UpToDate, Sept, Cucchiara B.L. and Pacelli, J.P., 2011

Clinicopathologic Conference, Cystoisospora Belli Enteritis and HIV Infection
NEJM 365:2306-2316, Case 38-2011, 2011

Antiretroviral Prophylaxis: A Defining Moment in HIV Control
Lancet 378:e23-25, Karim, S.S. and Karim, Q.A., 2011

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Inflammatory Cortical Demyelination in Early Sclerosis
NEJM 365:2188-2197, Lucchinetti, C.F.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

Primary CNS Plasmablastic Lymphoma: Report of a Case with CSF Cytology, Flow Cytometry, Radiology, Histological Correlation, and Review of the Literature
Diagn Cytopath 39:616-620, Rodriguez, P.A.,et al, 2011

Results of the Expanded HIV Testing Initiative - 25 Jurisdictions, United States 2007-2010
JAMA 306:698-700, , 2011

Azathioprine
Neurol 77:659-666, Costanzi, C.,et al, 2011

Screening for HIV Infection A Healthy, "Low-Risk" 42-Year-Old Man
JAMA 306:637-644, Libman, H., 2011

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011

Progressive Multifocal Leukoencephalopathy: Prognosis and treatment
UpToDate, June, Koralnik, I.J.,et al, 2011

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

"Im fine; Im just waiting for my disease" The New and Growing Class of Presymptomatic Patients
Neurol 77:522-523, Kwon, J.M.et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Routine HIV Screening - What Counts in Evidence-Based Policy?
NEJM 365:1265-1268, Bayer, R. and Oppenheimer G.M., 2011

HIV Screening of Male Inmates During Prison Intake Medical Evaluation - Washington, 2006-2010
JAMA 306:1756-1757, Strick, L.B., 2011

Syndrome of Inappropriate Antidiuresis May Herald or Accompany Neuromyelitis Optica
Neurol 77:1644-1645, Iorio, R.,et al, 2011

Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
Neurol 77:1561-1564, Abbas, M.,et al, 2011

Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
BMJ 343:d6016,d6015, May, M.,et al, 2011

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Yellow Fever Vaccination and Increased Relapse Rate in Travelers with Multiple Sclerosis
Arch Neurol 68:1267-1271, Farez, M.F. and Correale, J., 2011

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011

Acute Myeloid Leukemia in Italian Patients with Multiple Sclerosis Treated with Mitoxantrone
Neurol 77:1887-1895, Martinelli, V.,et al, 2011

Clinical Characteristics of Pediatric-onset Neuro-Behcet Disease
Neurol 77:1900-1905, Uludiz, D.,et al, 2011

Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011

A Strange Case of Waitress Headache
Lancet 378:1824, Libera, D.D.,et al, 2011

Ring Sign on Diffusion-Weighted Imaging
Arch Neurol 68:1474, Finelli, P.F. and Uphoff, D.F., 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011

Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011

Predicting motor outcome and death in term hypoxic-ischemic encephalopathy
Neurol 76:2055-2061, Martinez-Biarge, M.,et al, 2011

Sustained motion perception deficit following optic neuritis Behavioral and cortical evidence
Neurol 76:2103-2111, Raz, N.,et al, 2011

Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011

Disability, distress and unemployment in neurology outpatients with symptoms unexplained by organic disease
JNNP 82:810-813, 710, Carson, A.,et al, 2011

Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011

Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Stroke 42:2503-2508, Hannon, N.,et al, 2011

Fulminant Encephalopathy with Basal Ganglia Hyperintensities in HIV-infected Drug Users
Neurol 77:923, Finelli, P.F., 2011

Balos Concentric Sclerosis
NEJM 365:742, Wengert, O.,et al, 2011

Cerebral Venous Sinus Thrombosis Associated with Cerebral Hemorrhage Is Anticoagulant Treatment Safe?
The Neurologist 17:208-210, Fuentes, B.,et al, 2011

When A Brain Lesion Necessitates Chest CT
Conn Med 75:143-146, Finelli,P.F., 2011

Increasing Incidence of Ischemic Stroke in Patients With HIV Infection
Neurol 76:444-450, Ovbiagele,B. &Nath,A., 2011

Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Ann Neurol 69:292-302, 234, Polman,C.H.,et al, 2011

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011



Showing articles 1000 to 1050 of 4200 << Previous Next >>